Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
The Washington Informer18h
GLOVER/CHAVIS: Anti-Obesity Medicines Are Not All Created Equally
Illegal networks are flooding the market with counterfeit weight loss drugs, posing a serious threat to public health. The ...
Good Morning America18h
Compound versions of some weight loss drugs to be restricted
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Chemistry World21h
Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly
Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss pharmaceutical firm signed an exclusive agreement with Zealand Pharma to produce ...
97.5 WOKQ Radio23h
Maine Man Makes National Headlines for Weight Loss Journey
Justin Dudley, a dad from Maine was totally in that boat. He described having to get his photo taken at events as ...